, Volume 55, Issue 5, pp 631–643 | Cite as

Chronotherapeutics for Cardiovascular Disease

  • Yusra Anis Anwar
  • William B. White
Review Article


Chronotherapeutics, or delivery of a medication in concentrations that vary according to physiological need at different times during the dosage period, is a relatively new practice in clinical medicine. Epidemiological studies document that the incidence of many cardiovascular diseases, including myocardial infarction and stroke, varies predictably in time over 24 hours (the circadian period). Advanced diagnostic technologies using ambulatory monitoring of the blood pressure and electrocardiogram have also demonstrated that there is marked variability in the level of pressure in hypertensive patients and the degree of myocardial ischaemia in patients with coronary disease. These diagnostic techniques also allow us to study the effects of varying the timing of administration or delivery of a concentration of a drug on end-points such as changes in blood pressure, heart rate or intensity of angina.

The first chronotherapeutic agent for hypertension and angina pectoris, controlled onset, extended release (COER-24) verapamil, has recently been developed and registered in the US, Brazil, Canada and Mexico. The theoretical advantage of this formulation is that delivery of the active drug, verapamil, has been tailored to the typical circadian rhythm of blood pressure and heart rate in patients with hypertension and angina to better cover the early morning hours when cardiovascular need appears to be the greatest. An outcome study (CONVINCE) that evaluates primary prevention of cardiovascular events with this chronotherapy versus standard of care therapy is under way in several countries in North and South America and Europe.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Smolensky MH. Chronobiology and chronotherapeutics: applications to cardiovascular medicine. Am J Hypertens 1996; 9: 11S-21SGoogle Scholar
  2. 2.
    Smolensky MH, D’Alonzo GE. Medical chronobiology: concepts and applications. Am Rev Respir Dis 1993; 147: S2–19PubMedCrossRefGoogle Scholar
  3. 3.
    Mansoor GA, White WB. Ambulatory blood pressure and cardiovascular risk stratification. J Vasc Med Biol 1994; 5: 61–8Google Scholar
  4. 4.
    White WB, Schulman P, McCabe EJ, et al. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989; 261: 873–7PubMedCrossRefGoogle Scholar
  5. 5.
    Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985; 313: 1315–22PubMedCrossRefGoogle Scholar
  6. 6.
    Marler JR, Price TR, Clark GL, et al. Morning increase in onset of ischemic stroke. Stroke 1989; 20: 473–6PubMedCrossRefGoogle Scholar
  7. 7.
    Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood pressure. Lancet 1978; I: 795–7CrossRefGoogle Scholar
  8. 8.
    White WB. Circadian variation of blood pressure. Blood Press Monit 1997; 2: 46–51Google Scholar
  9. 9.
    Mansoor GA, McCabe EJ, White WB. The long-term reproducibility of ambulatory blood pressure. J Hypertens 1994; 12: 703–8PubMedCrossRefGoogle Scholar
  10. 10.
    Pickering TG, Kaplan NM, Krakoff L, et al. American Society of Hypertension Expert Panel: conclusions and recommendations on the clinical use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1996; 9: 1–11PubMedCrossRefGoogle Scholar
  11. 11.
    White WB, Morganroth J. Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy. Am J Cardiol 1989; 63: 94–8PubMedCrossRefGoogle Scholar
  12. 12.
    Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793–801PubMedCrossRefGoogle Scholar
  13. 13.
    Pickering TG. The clinical significance of diurnal blood pressure variations: dippers and nondippers. Circulation 1990; 81: 700–2PubMedCrossRefGoogle Scholar
  14. 14.
    Kario K, Matsuo T, Kobayashi H, et al. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertenisve patients: advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27: 130–5PubMedCrossRefGoogle Scholar
  15. 15.
    Willich SN, Linderer T, Wegscheider K, et al. Increased morning incidence of myocardial infarction in the ISAM study: absence with prior beta-adrenergic blockade. Circulation 1989; 80: 853–8PubMedCrossRefGoogle Scholar
  16. 16.
    Tofler GH, Muller JE, Stone PH, et al. Modifiers of timing and possible triggers of acute myocardial infarction in the Throm-bolysis in Myocardial Infarction Phase II (TIMI II) study group. J Am Coll Cardiol 1992; 20: 1049–55PubMedCrossRefGoogle Scholar
  17. 17.
    Johnstone MT, Mittleman M, Tofler G, et al. The pathophysiology of the onset of morning cardiovascular events. Am J Hypertens 1996; 9: 22S-8SGoogle Scholar
  18. 18.
    Mulcahy D, Keegan J, Cunningham D, et al. Circadian variation of total ischaemic burden and its alteration with anti-anginal agents. Lancet 1988; II: 755–9CrossRefGoogle Scholar
  19. 19.
    Tofler GH, Brezinski D, Schafer AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987; 316: 1514–8PubMedCrossRefGoogle Scholar
  20. 20.
    Rocco MB, Barry J, Campbell S, et al. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987; 75: 395–400PubMedCrossRefGoogle Scholar
  21. 21.
    Seigel D, Black DM, Seeley DG, et al. Circadian variation in ventricular arrhythmias in hypertensive men. Am J Cardiol 1992; 69: 344–7CrossRefGoogle Scholar
  22. 22.
    Raeder EA, Hahnloser SH, Graboys TB, et al. Spontaneous variability and circadian distribution of ectopic activity in patients with malignant ventricular arrythmia. J Am Coll Cardiol 1988; 12: 656–61PubMedCrossRefGoogle Scholar
  23. 23.
    Twidale N, Taylor S, Heddle WF, et al. Morning increase in the time of onset of sustained ventricular tachycardia. Am J Cardiol 1989; 64: 1204–6PubMedCrossRefGoogle Scholar
  24. 24.
    Cornelissen G, Bakkan E, Delmore P, et al. From various kinds of heart rate variability to chronocardiology. Am J Cardiol 1990; 66: 863–8PubMedCrossRefGoogle Scholar
  25. 25.
    Wood MA, Simpson PM, London WB, et al. Circadian pattern of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 1995; 25: 901–7PubMedCrossRefGoogle Scholar
  26. 26.
    Behrens S, Galecka M, Bruggemann T, et al. Circadian variation of sustained ventricular tachyarrhythmias terminated by appropriate shocks in patients with an implantable cardioverter defibrillator. Am Heart J 1995; 130: 79–84PubMedCrossRefGoogle Scholar
  27. 27.
    Lampert R, Rosenfeld L, Batsford W, et al. Circadian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter-defibrillators. Circulation 1994; 90: 241–7PubMedCrossRefGoogle Scholar
  28. 28.
    Venditti FJ, John RM, Hull M, et al. Circadian variation in defibrillation energy requirements. Circulation 1996; 94: 1607–12PubMedCrossRefGoogle Scholar
  29. 29.
    Lown B, Tykocinsky M, Garfein A, et al. Sleep and ventricular premature beats. Circulation 1973; 48: 691–701PubMedCrossRefGoogle Scholar
  30. 30.
    Pitzalis MV, Mastropasqua F, Massari F, et al. Sleep suppression of ventricular arrhythmias: a predictor of beta-blocker efficacy. Eur Heart J 1996; 17: 917–25PubMedCrossRefGoogle Scholar
  31. 31.
    Pietrucha A, Matysek Jerzy, Piwowarska W, et al. Analysis of circadian distribution of premature ventricular contractions in patients after heart transplantation. PACE 1994; 17(Pt II): 2064–7PubMedCrossRefGoogle Scholar
  32. 32.
    Sousa J, Kou W, Calkins H, et al. Effect of epinephrine on the efficacy of the internal cardioverter-defibrillator. Am J Cardiol 1992; 69: 509–12PubMedCrossRefGoogle Scholar
  33. 33.
    Wroe SJ, Sandercock P, Bamford J, et al. Diurnal variation in incidence of stroke: Oxfordshire community project. BMJ 1992; 304: 155–7PubMedCrossRefGoogle Scholar
  34. 34.
    Gallerani M, Manfredini R, Ricci L, et al. Chronobiological aspects of acute cerebrovascular diseases. Acta Neurol Scand 1993; 87: 482–7PubMedCrossRefGoogle Scholar
  35. 35.
    Argentino C, Toni D, Rasura M, et al. Circadian variation in the frequency of ischemic stroke. Stroke 1990; 21: 387–9PubMedCrossRefGoogle Scholar
  36. 36.
    Schillaci G, Verdecchia P, Benemio G, et al. Blood pressure rise and ischaemic stroke. Lancet 1995; 346: 1366–7PubMedCrossRefGoogle Scholar
  37. 37.
    Tsementzis SA, Gill JS, Hitchcock ER, et al. Diurnal variation of and activity during the onset of stroke. Neurosurgery 1985; 17: 901–4PubMedCrossRefGoogle Scholar
  38. 38.
    White WB. A chronotherapeutic approach to the management of hypertension. Am J Hypertens 1996; 9: 29S-33SGoogle Scholar
  39. 39.
    Sloan MA, Price TR, Foulkes MA, et al. Circadian rhythmicity of stroke onset — intracerebral and subarachanoid hemorrhage. Stroke 1992; 23: 1420–6PubMedCrossRefGoogle Scholar
  40. 40.
    Kleinpeter G, Schatzer R, Bock F. Is blood pressure really a trigger for the circadian rhythm of subarachanoid hemorrhage? Stroke 1995; 26: 1805–10PubMedCrossRefGoogle Scholar
  41. 41.
    Nakamura K, Oita J, Yamaguchi T. Nocturnal blood pressure dip in stroke survivors — a pilot study. Stroke 1995; 26: 1373–8PubMedCrossRefGoogle Scholar
  42. 42.
    White WB. Ambulatory blood pressure monitoring in the evaluation of hypertension therapy. Cardiol Clin North Am 1995; 13: 569–77Google Scholar
  43. 43.
    Mansoor WB, White WB. Contribution of ambulatory blood pressure monitoring to the design and analysis of antihypertensive therapy trials. J Cardiovasc Risk 1994; 1: 136–43PubMedGoogle Scholar
  44. 44.
    Palatini P, Racioppa A, Raule B, et al. Effect of timing of administration on the plasma ACE inhibitor activity and the anti-hypertensive effect of quinapril. Clin Pharmacol Ther 1992; 52: 378–83PubMedCrossRefGoogle Scholar
  45. 45.
    Sundberg S, Luurila OJ, Kohvakka A, et al. The circadian heart rate but not blood pressure profile is influenced by the timing of β-blocker administration in hypertensives. Eur J Clin Pharmacol 1991; 40: 435–6PubMedCrossRefGoogle Scholar
  46. 46.
    Greminger P, Suter PM, Holm D, et al. Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. Clin Investig 1994; 72: 864–9PubMedCrossRefGoogle Scholar
  47. 47.
    Mengden T, Binswanger B, Spuhler T, et al. The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening. J Hypertens 1993; 11: 1403–11PubMedCrossRefGoogle Scholar
  48. 48.
    Lemmer B. Ambulatory blood pressure in antihypertensive therapy. Blood Press Monit 1996; 1: 161–9PubMedGoogle Scholar
  49. 49.
    Mengden T, Binswanger B, Gruene S. Dynamics of drug compliance and 24-hour blood pressure control of once daily morning vs evening amlodipine [abstract]. JHypertens 1992; 10 Suppl. 4: S136Google Scholar
  50. 50.
    Fogari R, Malocco E, Tettamanti F, et al. Evening vs morning isradipine sustained release in essential hypertension: a double-blind study with 24 hour ambulatory monitoring. Br J Clin Pharmacol 1993; 35: 51–4PubMedCrossRefGoogle Scholar
  51. 51.
    Lemmer B, Sasse U, Witte K, et al. Pharmacokinetics and cardiovascular effects of a new sustained-release formulation of diltiazem [abstract]. Naunyn-Schmiedebergs Arch Pharmacol 1994; 349S: R141Google Scholar
  52. 52.
    Meilhac B, Mallion JM, Carre A, et al. Étude de l’influence de l’horaire de la prise sur l’effet antihypertenseur et la tolérance de la nitrendipine chez des patients hypertendus essentiels légers à modérés. Therapie 1992; 47: 205–10PubMedGoogle Scholar
  53. 53.
    Umeda T, Naomi S, Iwaoka K, et al. Timing of administration of am antihypertensive drug in the treatment of essential hypertension. Hypertension 1994; 23 Suppl. 1: 1211–4Google Scholar
  54. 54.
    Palatini P, Mos L, Mormino P, et al. Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring. Int J Clin Pharmcol Ther 1993; 31: 295–300Google Scholar
  55. 55.
    Witte K, Weisser K, Neubeck M, et al. Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Phamacol Ther 1993; 54: 177–86CrossRefGoogle Scholar
  56. 56.
    White WB, Anders RJ, Maclntyre JM, et al. Am J Cardiol 1995; 76: 375–80PubMedCrossRefGoogle Scholar
  57. 57.
    White WB, Black HR, Mehrotra D, et al. Effects of COER-verapamil on circadian variation of BP (dippers vs nondippers). Am J Cardiol 1997; 78: 469–74CrossRefGoogle Scholar
  58. 58.
    Cutler NR, Anders RJ, Jhee SS, et al. Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris. Am J Cardiol 1995; 75: 1102–6PubMedCrossRefGoogle Scholar
  59. 59.
    Decousus HA, Croze M, Levi FA, et al. Circadian changes of heparin infused at a constant rate. BMJ 1985; 290: 341–4PubMedCrossRefGoogle Scholar
  60. 60.
    Fargrell B, Arver S, Intaglietta A, et al. Changes of activated partial thromboplastin time during constant intravenous and fixed intermittent subcutaneous administration of heparin. J Int Med 1989; 225: 257–60CrossRefGoogle Scholar
  61. 61.
    Black HR, Elliott WJ, Neaton JD, et al. Rationale and design for the Controlled Onset Verapamil Investigation of Cardiovascular Endpoints (CONVINCE) Trial. Control Clin Trials. In pressGoogle Scholar

Copyright information

© Adis International Limited 1998

Authors and Affiliations

  • Yusra Anis Anwar
    • 1
  • William B. White
    • 1
  1. 1.Section of Hypertension and Clinical Pharmacology, Department of MedicineUniversity of Connecticut School of MedicineFarmingtonUSA

Personalised recommendations